|Articles|March 1, 2001
Cost Effectiveness and Quality of Life Considerations in the Treatment of Patients with Overactive Bladder
Author(s)William F. McGhan, PharmD, PhD
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Articles
- Overcoming Weight Bias in Health Care Systems
September 15th 2025
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Iron Dysregulation Linked to MS Progression, Review Finds
2
Efficacy of Ruxolitinib Cream in Nonsegmental Vitiligo Confirmed in Real-World Study
3
Metabolic Issues More Common in Patients With HIV
4
West Coast Health Alliance Releases First Vaccine Guidelines, Aiming to Replace CDC Recommendations
5